GLOBAL HEALTH LABGHL 01
Leveraging Evidence and Tools to Advance AMR Policy Implementation
From Data to Action
Date
Sunday, 12th October
Time
11:00-12:30 CEST
09:00-10:30 UTC
Room
Hub 1
Co-Host(s)
About the session
Despite increasing global and national commitments to tackle antimicrobial resistance (AMR), translating these into effective and sustained action remains a challenge. A core barrier is not only the lack of high-quality, cross-sectoral data—but also the underuse of available tools, standards, and evidence in informing decision-making and evaluating outcomes. This session brings together different perspectives on data, interventions and policy to explore how countries and stakeholders can better harness existing data and tools to plan, prioritize, and implement impactful interventions, particularly in low- and middle-income settings.
Strengthening both the generation and the strategic use of data, tools, and standards is essential for impactful and accountable AMR policy implementation. In this session we will talk about which specific AMR burden and surveillance data we need to better inform prioritization and implementation planning. How can we improve the use of evidence on which interventions work best across sectors and Regions. And how can implementation experiences and data from the field better inform future policy and investment decisions?
Strengthening both the generation and the strategic use of data, tools, and standards is essential for impactful and accountable AMR policy implementation. In this session we will talk about which specific AMR burden and surveillance data we need to better inform prioritization and implementation planning. How can we improve the use of evidence on which interventions work best across sectors and Regions. And how can implementation experiences and data from the field better inform future policy and investment decisions?
Speakers
Ralf Kuhlen
Fresenius SE & Co. KGaA
Chief Medical Officer
Germany
Open
Mohsen Naghavi
Institute for Health Metrics and Evaluation (IHME) at University of Washington
Professor and Director of Subnational Burden of Disease Estimation
United States of America
Open
Arshnee Moodley
International Livestock Research Institute (ICARS)
Team Leader Antimicrobial Resistance (AMR)
Kenya
Open
Kevin Outterson
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X)
Executive Director
United States of America
Open